Skip to main content
Year archive

INVERT GRAPHITE LIMITED — 2016 filings

All 47 regulatory filings released by INVERT GRAPHITE LIMITED (IVG) in 2016, sourced directly from the official regulator.

47 Filings
2016 Period
2016 filings (47)
Filing Released Lang
Phase II Clinical Trial - First Patient In 2 pages 128.9KB
Regulatory Filings
2016-12-19 English
Chairman's Address to AGM 3 pages 128.8KB
Regulatory Filings
2016-11-22 English
Executive Team presentation to AGM 22 pages 2.6MB
Regulatory Filings
2016-11-22 English
AGM Results of Meeting 2 pages 162.6KB
Regulatory Filings
2016-11-22 English
Constitution of Factor Therapeutics Limited 55 pages 468.2KB
Regulatory Filings
2016-11-22 English
Appendix 3B - unlisted share options following AGM 13 pages 157.0KB
Regulatory Filings
2016-11-22 English
Appendix 3Y - Dr Robert Ryan (options) 2 pages 74.9KB
Regulatory Filings
2016-11-22 English
Appendix 3Y - Dr Cherrell Hirst (correction) 3 pages 74.6KB
Regulatory Filings
2016-11-22 English
Appendix 3Y - Dr Chris Behrenbruch (correction) 3 pages 75.7KB
Regulatory Filings
2016-11-22 English
Appendix 3Y - Mr Tim Hughes (correction) 3 pages 74.9KB
Regulatory Filings
2016-11-22 English
Investor Update 27 pages 2.9MB
Regulatory Filings
2016-11-21 English
Collaboration and IP option agreement with Monash University 2 pages 130.8KB
Regulatory Filings
2016-11-21 English
Human Capital Update 2 pages 138.9KB
Regulatory Filings
2016-11-20 English
VF001 - Clinical Presentation 14 pages 2.3MB
Regulatory Filings
2016-11-08 English
FDA - lift of clincial hold 1 page 313.8KB
Regulatory Filings
2016-11-06 English
Notification of Investor Conference Call 2 pages 123.2KB
Regulatory Filings
2016-11-06 English
Edison initiates research coverage 1 page 113.3KB
Regulatory Filings
2016-10-30 English
Appendix 4C for the September Quarter 5 pages 1.0MB
Regulatory Filings
2016-10-26 English
Appendix 4G - key to corporate governance disclosures 12 pages 167.9KB
Regulatory Filings
2016-10-23 English
Corporate Governance Statement 11 pages 458.9KB
Regulatory Filings
2016-10-23 English
Annual Report to Shareholders 58 pages 1.6MB
Regulatory Filings
2016-10-23 English
AGM Notice of Meeting, Proxy and Proposed Constitution 78 pages 1.7MB
Regulatory Filings
2016-10-20 English
Submission of IND amendments for Phase II study 1 p
Regulatory Filings
2016-10-09 English
Shareholder Update 9 pages 828.2KB
Regulatory Filings
2016-10-03 English
Company Secretary Appointment 1 page 82.3KB
Regulatory Filings
2016-09-28 English
Change of Registered Address 1 page 82.3KB
Regulatory Filings
2016-09-28 English
Director Appointment 2 pages 101.1KB
Regulatory Filings
2016-09-13 English
Initial Director's Interest Notice 2 pages 82.6KB
Regulatory Filings
2016-09-13 English
Completion of Manufacturing 1 page 111.7KB
Regulatory Filings
2016-09-08 English
Appendix 3B 13 pages 167.9KB
Regulatory Filings
2016-08-23 English
Appendix 4E - Preliminary Final Report 2 pages 190.0KB
Regulatory Filings
2016-08-16 English
Financial Report YE 30 June 2016 50 pages 1.1MB
Regulatory Filings
2016-08-16 English
Formation of Medical Advisory Board 4 pages 157.9KB
Regulatory Filings
2016-08-02 English
Appendix 3B 13 pages 168.3KB
Regulatory Filings
2016-08-02 English
Appendix 4C - quarterly 5 pages 131.6KB
Regulatory Filings
2016-07-27 English
Cleansing notice s708A(5)(e) 2 pages 76.7KB
Regulatory Filings
2016-07-25 English
Appendix 3B 13 pages 169.8KB
Regulatory Filings
2016-07-25 English
Change of Director's Interest Notice - C Hirst 2 pages 103.4KB
Regulatory Filings
2016-07-25 English
Change of Director's Interest Notice - C Behrenbruch 2 pages 105.9KB
Regulatory Filings
2016-07-25 English
Shareholder Quarterly Update 4 pages 7.2MB
Regulatory Filings
2016-07-13 English
Appendix 3B 13 pages 176.2KB
Regulatory Filings
2016-06-30 English
Results of Meeting 1 page 64.4KB
Regulatory Filings
2016-06-28 English
Clinical Trial Update 2 pages 87.7KB
Regulatory Filings
2016-06-14 English
Notice of Extraordinary General Meeting/Proxy Form 14 pages 452.8KB
Regulatory Filings
2016-05-22 English
Shareholder Update 17 pages 1.3MB
Regulatory Filings
2016-05-16 English
Becoming a substantial holder 3 pages 78.1KB
Regulatory Filings
2016-05-05 English
TIS Completes Corporate Re-branding to Factor Therapeutics 2 pages 117.0KB
Regulatory Filings
2016-05-04 English